StockData

Translational Development Acquisition Corp. (TDAC) stock

TDACNasdaqBlank ChecksFiscal year ends December 31Also trades as TDACU, TDACW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$10.87+0.01 (+0.09%)

Close on Nov 17, 2026Market cap $209.89MP/E –Yield –

Translational Development Acquisition r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Translational Development Acquisition

Translational Development Acquisition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Translational Development Acquisition figures

See a number that looks wrong?